Apoferritin applications in nanomedicine

Nanomedicine

Volumn 9, Issue 14, 2014, Pages 2233-2245

  Heger, Zbynek ^a   Skalickova, Sylvie ^a   Zitka, Ondrej ^a,b   Adam, Vojtech ^a,b   Kizek, Rene ^a,b  

^a MENDEL UNIVERSITY IN BRNO   (Czech Republic)

^b BRNO UNIVERSITY OF TECHNOLOGY   (Czech Republic)

Author keywords

Horse spleen ferritin; Magnetic resonance imaging; Nanoscale; Nanotrasporter; Photodynamic therapy; Self assembly; Therapeutic agents

Indexed keywords

APOFERRITIN; BACTERIOFERRITIN; CARBOPLATIN; CERULOPLASMIN; CISPLATIN; DAUNORUBICIN; DOXORUBICIN; DPS PROTEIN; FERRITIN; FLUOROURACIL; INACTIVATED VACCINE; MANGANESE; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; DRUG CARRIER;

BIOASSAY; GENE DELIVERY SYSTEM; GENE THERAPY; HUMAN; NANOMEDICINE; PHOTODYNAMIC THERAPY; PROTEIN ASSEMBLY; PROTEIN STRUCTURE; REVIEW; CHEMISTRY; GENETIC PROCEDURES; PROTEIN CONFORMATION;

APOFERRITINS; BIOSENSING TECHNIQUES; DRUG CARRIERS; GENETIC THERAPY; HUMANS; NANOMEDICINE; PROTEIN CONFORMATION;

EID: 84911496218     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/NNM.14.119     Document Type: Review

References (117)

1. Crichton R. Intracellular iron storage and biomineralisation. In: Iron Metabolism (Eds). John Wiley & Sons Ltd, NY, USA, 183-222 (2009).
2. Bou-Abdallah F, Zhao G, Biasiotto G, Poli M, Arosio P, Chasteen ND. Facilitated diffusion of iron(II) and dioxygen substrates into human H-chain ferritin. A fluorescence and absorbance study employing the ferroxidase center substitution Y34W. J. Am. Chem. Soc. 130 (52), 17801-17811 (2008).
3. Bulvik BE, Berenshtein E, Meyron-Holtz EG, Konijn AM, Chevion M. Cardiac protection by preconditioning is generated via an iron-signal sreated by proteasomal degradation of iron proteins. PLoS ONE 7 (11), 1-9 (2012).
4. Ullrich A, Horn S. Structural investigations on differently sized monodisperse iron oxide nanoparticles synthesized by remineralization of apoferritin molecules. J. Nanopart. Res. 15 (8), 1-9 (2013).
5. Zhen ZP, Tang W, Guo CL et al. Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer. ACS Nano 7(8), 6988-6996 (2013).
6. Smith JL. The physiological role of ferritin-like compounds in bacteria. Crit. Rev. Microbiol. 30 (3), 173-185 (2004).
7. Liu XF, Theil EC. Ferritins: dynamic management of biological iron and oxygen chemistry. Acc. Chem. Res. 38 (3), 167-175 (2005).
8. Rakshit T, Mukhopadhyay R. Tuning band gap of holoferritin by metal core reconstitution with Cu, Co, and Mn. Langmuir 27 (16), 9681-9686 (2011).
9. Rouault TA. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat. Chem. Biol. 2 (8), 406-414 (2006).
10. Zhen ZP, Tang W, Chen HM et al. RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors. ACS Nano 7 (6), 4830-4837 (2013).
11. Hou JX, Yamada S, Kajikawa T et al. Role of ferritin in the cytodifferentiation of periodontal ligament cells. Biochem. Biophys. Res. Commun. 426(4), 643-648 (2012).
12. Zhao J, Liu ML, Zhang YY, Li HT, Lin YH, Yao SZ. Apoferritin protein nanoparticles dually labeled with aptamer and horseradish peroxidase as a sensing probe for thrombin detection. Anal. Chim. Acta 759, 53-60 (2013).
13. Shevchenko EV, Talapin DV, Kotov NA, O'brien S, Murray CB. Structural diversity in binary nanoparticle superlattices. Nature 439 (7072), 55-59 (2006).
14. Roney C, Kulkarni P, Arora V et al. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. J. Control. Release 108 (2-3), 193-214 (2005).
15. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J. Control. Release 100 (1), 5-28 (2004).
16. Chomoucka J, Drbohlavova J, Huska D, Adam V, Kizek R, Hubalek J. Magnetic nanoparticles and targeted drug delivering. Pharmacol. Res. 62 (2), 144-149 (2010).
17. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-coglycolide) and its derivatives. J. Control. Release 125 (3), 193-209 (2008).
18. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70 (1-2), 1-20 (2001).
19. Andrews SC. Iron storage in bacteria. Adv. Microb. Physiol. 40, 281-351 (1998).
20. Andrews SC, Robinson AK, Rodriguez-Quinones F. Bacterial iron homeostasis. FEMS Microbiol. Rev. 27 (2-3), 215-237 (2003).
21. Frolow F, Kalb AJ, Yariv J. Structure of a unique twofold symmetrical heme-binding site. Nat. Struct. Biol. 1 (7), 453-460 (1994).
22. Douglas T, Stark VT. Nanophase cobalt oxyhydroxide mineral synthesized within the protein cage of ferritin. Inorg. Chem. 39 (8), 1828-1830 (2000).
23. Chen G, Zhu XL, Meng FB, Yu ZG, Li GX. Apoferritin as a bionanomaterial to facilitate the electron transfer reactivity of hemoglobin and the catalytic activity towards hydrogen peroxide. Bioelectrochemistry 72 (1), 77-80 (2008).
24. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 99 (10), 3505-3516 (2002).
25. Fukano H, Takahashi T, Aizawa M, Yoshimura H. Synthesis of uniform and dispersive calcium carbonate nanoparticles in a protein cage through control of electrostatic potential. Inorg. Chem. 50 (14), 6526-6532 (2011).
26. Caskey JH, Jones C, Miller YE, Seligman PA. Human ferritin gene is assigned to chromosome-19. Proc. Natl Acad. Sci. USA 80 (2), 482-486 (1983).
27. Worwood M, Brook JD, Cragg SJ et al. Assignment of human ferritin genes to chromosomes-11 and chromosome-19q13.3-19qter. Hum. Genet. 69 (4), 371-374 (1985).
28. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275 (3), 161-203 (1996).
29. Uto K, Yamamoto K, Kishimoto N, Muraoka M, Aoyagi T, Yamashita I. Characterization of stable, electroactive protein cage/synthetic polymer multilayer thin films prepared by layer-by-layer assembly. J. Nanopart. Res. 15(4), 1-11 (2013).
30. De Val N, Declercq JP, Lim CK, Crichton RR. Structural analysis of haemin demetallation by L-chain apoferritins. J. Inorg. Biochem. 112, 77-84 (2012).
31. Ciasca G, Chiarpotto M, Campi G et al. Reconstitution of aluminium and iron core in horse spleen apoferritin. J. Nanopart. Res. 13 (11), 6149-6155 (2011).
32. Iwahori K, Yoshizawa K, Muraoka M, Yamashita I. Fabrication of ZnSe nanoparticles in the apoferritin cavity by designing a slow chemical reaction system. Inorg. Chem. 44 (18), 6393-6400 (2005).
33. Suzumoto Y, Okuda M, Yamashita I. Fabrication of zinc oxide semiconductor nanoparticles in the apoferritin cavity. Cryst. Growth Des. 12(8), 4130-4134 (2012).
34. Galvez N, Sanchez P, Dominguez-Vera JM. Preparation of Cu and CuFe Prussian Blue derivative nanoparticles using the apoferritin cavity as nanoreactor. Dalton Trans. (15), 2492-2494 (2005).
35. Tian LX, Cao CQ, Pan YX. The influence of reaction temperature on biomineralization of ferrihydrite cores in human H-ferritin. Biometals 25(1), 193-202 (2012).
36. Abe S, Hirata K, Ueno T et al. Polymerization of phenylacetylene by rhodium complexes within a discrete space of apo-ferritin. J. Am. Chem. Soc. 131 (20), 6958-6960 (2009).
37. Liu GD, Wang J, Wu H, Lin YH. Versatile apoferritin nanoparticle labels for assay of protein. Anal. Chem. 78 (21), 7417-7423 (2006).
38. Liu F, Du BJ, Chai Z, Zhao GH, Ren FZ, Leng XJ. Binding properties of apoferritin to nicotinamide and calcium. Eur. Food Res. Technol. 235(5), 893-899 (2012).
39. Uchida M, Flenniken ML, Allen M et al. Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J. Am. Chem. Soc. 128 (51), 16626-16633 (2006).
40. Banyard SH, Stammers DK, Harrison PM. Electron-density map of apoferritin at 2.8-A resolution. Nature 271 (5642), 282-284 (1978).
41. Dominguez-Vera JM, Colacio E. Nanoparticles of Prussian Blue ferritin: a new route for obtaining nanomaterials. Inorg. Chem. 42 (22), 6983-6985 (2003).
42. Kim M, Rho Y, Jin KS et al. pH-dependent structures of ferritin and apoferritin in solution: disassembly and reassembly. Biomacromolecules 12 (5), 1629-1640 (2011).
43. Gerl M, Jaenicke R. Mechanism of the self-assembly of apoferritin from horse spleen - cross-linking and spectroscopic analysis. Eur. Biophys. J. Biophys. Lett. 15 (2), 103-109 (1987).
44. Makino A, Harada H, Okada T et al. Effective encapsulation of a new cationic gadolinium chelate into apoferritin and its evaluation as an MRI contrast agent. Nanomed. Nanotechnol. Biol. Med. 7 (5), 638-646 (2011).
45. Li JY, Paragas N, Ned RM et al. Scara5 Is a ferritin receptor mediating non-transferrin iron delivery. Dev. Cell 16 (1), 35-46 (2009).
46. Aime S, Frullano L, Crich SG. Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew. Chem. Int. Edit. 41 (6), 1017-1019 (2002).
47. Cutrin JC, Crich SG, Burghelea D, Dastru W, Aime S. Curcumin/Gd loaded apoferritin: a novel 'theranostic' agent to prevent hepatocellular damage in toxic induced acute hepatitis. Mol. Pharm. 10(5), 2079-2085 (2013).
48. Crich SG, Cutrin JC, Lanzardo S et al. Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model. Contrast Media Mol. Imaging 7(3), 281-288 (2012).
49. Matsumura S, Aoki I, Saga T, Shiba K. A tumor-environment-responsive nanocarrier that evolves its surface properties upon sensing matrix metalloproteinase-2 and initiates agglomeration to enhance T-2 relaxivity for magnetic resonance imaging. Mol. Pharm. 8 (5), 1970-1974 (2011).
50. Sun CJ, Yang H, Yuan Y et al. Controlling assembly of paired gold clusters within apoferritin nanoreactor for in vivo kidney targeting and biomedical imaging. J. Am. Chem. Soc. 133 (22), 8617-8624 (2011).
51. Valero E, Tambalo S, Marzola P et al. Magnetic nanoparticles-templated assembly of protein subunits: a new platform for carbohydrate-based MRI nanoprobes. J. Am. Chem. Soc. 133 (13), 4889-4895 (2011).
52. Simsek E, Kilic MA. Magic ferritin: a novel chemotherapeutic encapsulation bullet. J. Magn. Magn. Mater. 293 (1), 509-513 (2005).
53. Kilic MA. Ozlu E, Calis S. A novel protein-based anticancer drug encapsulating nanosphere: apoferritin-doxorubicin complex. J. Biomed. Nanotechnol. 8(3), 508-514 (2012).
54. Blazkova I, Nguyen HV, Dostalova S et al. Apoferritin modified magnetic particles as doxorubicin carriers for anticancer drug delivery. Int. J. Mol. Sci. 14(7), 13391-13402 (2013).
55. Yang Z, Wang XY, Diao HJ et al. Encapsulation of platinum anticancer drugs by apoferritin. Chem. Commun. 43 (33), 3453-3455 (2007).
56. Xing RM, Wang XY, Zhang CL et al. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin. J. Inorg. Biochem. 103 (7), 1039-1044 (2009).
57. Ma-Ham AH, Wu H, Wang J, Kang XH, Zhang YY, Lin YH. Apoferritin-based nanomedicine platform for drug delivery: equilibrium binding study of daunomycin with DNA. J. Mater. Chem. 21 (24), 8700-8708 (2011).
58. + cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis. J. Immunol. 177 (5), 3406-3412 (2006).
59. Liu XY, Wei W, Huang SJ et al. Bio-inspired protein-gold nanoconstruct with core-void-shell structure: beyond a chemo drug carrier. J. Mat. Chem. B 1(25), 3136-3143 (2013).
60. Bradshaw TD, Junor M, Patane A et al. Apoferritin-encapsulated PbS quantum dots significantly inhibit growth of colorectal carcinoma cells. J. Mat. Chem. B 1(45), 6254-6260 (2013).
61. Mougin NC, Van Rijn P, Park H, Muller AHE, Boker A. Hybrid capsules via self-assembly of thermoresponsive and interfacially active bionanoparticle-polymer conjugates. Adv. Funct. Mater. 21 (13), 2470-2476 (2011).
62. Huang HW, Yu Q, Peng XS, Ye ZZ. Mesoporous protein thin films for molecule delivery. J. Mater. Chem. 21 (35), 13172-13179 (2011).
63. Moss D, Powell LW, Arosio P, Halliday JW. Effect of cell-proliferation on H-ferritin receptor expression in human T-lymphoid (MOLT-4) cells. J. Lab. Clin. Med. 120 (2), 239-243 (1992).
64. Fargion S, Fracanzani AL, Cislaghi V, Levi S, Cappellini MD, Fiorelli G. Characteristic of the membrane-receptor for human-ferritin. Curr. Stud. Hematol. Blood Transfus.(58), 164-170 (1991).
65. Hulet SW, Menzies S, Connor JR. Ferritin binding in the developing mouse brain follows a pattern similar to myelination and is unaffected by the jimpy mutation. Dev. Neurosci. 24 (2-3), 208-213 (2002).
66. Li L, Fang CJ, Ryan JC et al. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc. Natl Acad. Sci. USA 107 (8), 3505-3510 (2010).
67. 2 nano-truffle that has excellent artificial redox enzyme activity. Chem. Commun. 48(26), 3155-3157 (2012).
68. Kanekiyo M, Wei CJ, Yassine HM et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499(7456), 102-106 (2013).
69. Saboktakin MR, Tabatabaee RM. The novel polymeric systems for photodynamic therapy technique. Int. J. Biol. Macromol. 65, 398-414 (2014).
70. Marrelli M, Menichini G, Provenzano E, Conforti F. Applications of natural compounds in the photodynamic therapy of skin cancer. Curr. Med. Chem. 21(12), 1371-1390 (2014).
71. Yan F, Zhang Y, Yuan HK, Gregas MK, Vo-Dinh T. Apoferritin protein cages: a novel drug nanocarrier for photodynamic therapy. Chem. Commun. 44 (38), 4579-4581 (2008).
72. Yan F, Zhang Y, Kim KS, Yuan HK, Vo-Dinh T. Cellular uptake and photodynamic activity of protein nanocages containing Methylene Blue photosensitizing drug. Photochem. Photobiol. 86 (3), 662-666 (2010).
73. Garcia AM, Alarcon E, Munoz M, Scaiano JC, Edwards AM, Lissi E. Photophysical behaviour and photodynamic activity of zinc phthalocyanines associated to liposomes. Photochem. Photobiol. Sci. 10 (4), 507-514 (2011).
74. Liu YY, Chang Y, Yang C et al. Biodegradable nanoassemblies of piperlongumine display enhanced anti-angiogenesis and anti-tumor activities. Nanoscale 6(8), 4325-4337 (2014).
75. Mao X, Liu GD. Nanomaterial based electrochemical DNA biosensors and bioassays. J. Biomed. Nanotechnol. 4 (4), 419-431 (2008).
76. Liu GD, Lin YH. Nanomaterial labels in electrochemical immunosensors and immunoassays. Talanta 74 (3), 308-317 (2007).
77. Liu GD, Wang J, Wu H, Lin YY, Lin YH. Nanovehicles based bioassay labels. Electroanalysis 19 (7-8), 777-785 (2007).
78. Kim SE, Ahn KY, Park JS et al. Fluorescent ferritin nanoparticles and application to the aptamer sensor. Anal. Chem. 83 (15), 5834-5843 (2011).
79. Liu GD, Wang J, Lea SA, Lin YH. Bioassay labels based on apoferritin nanovehicles. ChemBioChem 7 (9), 1315-1319 (2006).
80. Pumera M, Sanchez S, Ichinose I, Tang J. Electrochemical nanobiosensors. Sens. Actuator B Chem. 123 (2), 1195-1205 (2007).
81. Okuda M, Iwahori K, Yamashita I, Yoshimura H. Fabrication of nickel and chromium nanoparticles using the protein cage of apoferritin. Biotechnol. Bioeng. 84 (2), 187-194 (2003).
82. Ueno T, Suzuki M, Goto T, Matsumoto T, Nagayama K, Watanabe Y. Size-selective olefin hydrogenation by a Pd nanocluster provided in an apo-ferritin cage. Angew. Chem. Int. Edit. 43 (19), 2527-2530 (2004).
83. Kramer RM, Li C, Carter DC, Stone MO, Naik RR. Engineered protein cages for nanomaterial synthesis. J. Am. Chem. Soc. 126 (41), 13282-13286 (2004).
84. Yamashita I, Hayashi J, Hara M. Bio-template synthesis of uniform CdSe nanoparticles using cage-shaped protein, apoferritin. Chem. Lett. 33 (9), 1158-1159 (2004).
85. Douglas T, Dickson DPE, Betteridge S, Charnock J, Garner CD, Mann S. Synthesis and structure of an iron(III) sulfide-ferritin bioinorganic nanocomposite. Science 269 (5220), 54-57 (1995).
86. Okuda M, Kobayashi Y, Suzuki K et al. Self-organized inorganic nanoparticle arrays on protein lattices. Nano Lett. 5 (5), 991-993 (2005).
87. Meldrum FC, Colfen H. Controlling mineral morphologies and structures in biological and synthetic systems. Chem. Rev. 108 (11), 4332-4432 (2008).
88. 2+-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T-1-weighted MRI. Biomaterials 34(35), 8941-8948 (2013).
89. Kim SM, Chae MK, Yim MS et al. Hybrid PET/MR imaging of tumors using an oleanolic acid-conjugated nanoparticle. Biomaterials 34(33), 8114-8121 (2013).
90. Cui YN, Xu QX, Chow PKH, Wang DP, Wang CH. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials 34(33), 8511-8520 (2013).
91. Ojer P, Neutsch L, Gabor F, Irache JM, De Cerain AL. Cytotoxicity and cell interaction studies of bioadhesive poly(anhydride) nanoparticles for oral antigen/drug delivery. J. Biomed. Nanotechnol. 9 (11), 1891-1903 (2013).
92. Wang AF, Qi WX, Wang N et al. A smart nanoporous theranostic platform for simultaneous enhanced MRI and drug delivery. Microporous Mesoporous Mat. 180, 1-7 (2013).
93. Kang HW, Yeo J, Hwang JO et al. Simple ZnO nanowires patterned growth by microcontact printing for high performance field emission device. J. Phys. Chem. C 115 (23), 11435-11441 (2011).
94. Okuda M, Suzumoto Y, Yamashita I. Bioinspired synthesis of homogenous cerium oxide nanoparticles and two- or three-dimensional nanoparticle arrays using protein supramolecules. Cryst. Growth Des. 11 (6), 2540-2545 (2011).
95. Meldrum FC, Wade VJ, Nimmo DL, Heywood BR, Mann S. Synthesis of inorganic nanophase materials in supramolecular protein cages. Nature 349 (6311), 684-687 (1991).
96. Toussaint L, Bertrand L, Hue L, Crichton RR, Declercq JP. High-resolution x-ray structures of human apoferritin H-chain mutants correlated with their activity and metal-binding sites. J. Mol. Biol. 365 (2), 440-452 (2007).
97. Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther. 9 (24), 1647-1652 (2002).
98. Hosseinkhani H, He WJ, Chiang CH et al. Biodegradable nanoparticles for gene therapy technology. J. Nanopart. Res. 15(7), 1-15 (2013).
99. Chaturvedi K, Ganguly K, Kulkarni AR et al. Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review. Expert Opin. Drug Deliv. 8 (11), 1455-1468 (2011).
100. Rudzinski WE, Aminabhavi TM. Chitosan as a carrier for targeted delivery of small interfering RNA. Int. J. Pharm. 399 (1-2), 1-11 (2010).
101. Mahato RI. Non-viral peptide-based approaches to gene delivery. J. Drug Target. 7 (4), 249-268 (1999).
102. Tan PH, Chan CLH, George AJT. Strategies to improve nonviral vectors - potential applications in clinical transplantation. Expert Opin. Biol. Ther. 6 (6), 619-630 (2006).
103. Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 29 (24-25), 3477-3496 (2008).
104. Hsu CYM, Uludag H. Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression. J. Drug Target. 20(4), 301-328 (2012).
105. Valle-Delgado JJ, Molina-Bolivar JA, Galisteo-Gonzalez F, Galvez-Ruiz MJ, Feiler A, Rutland MW. Existence of hydration forces in the interaction between apoferritin molecules adsorbed on silica surfaces. Langmuir 21 (21), 9544-9554 (2005).
106. Liao N, Zhuo Y, Chai YQ et al. Amplified electrochemiluminescent immunosensing using apoferritin-templated poly(ethylenimine) nanoparticles as co-reactant. Chem. Commun. 48(61), 7610-7612 (2012).
107. Gosselin MA, Guo WJ, Lee RJ. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug. Chem. 12 (6), 989-994 (2001).
108. Fischer D, Bieber T, Li YX, Elsasser HP, Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharmacol. Res. 16 (8), 1273-1279 (1999).
109. Mcmahon HT, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 12 (8), 517-533 (2011).
110. Mounkes LC, Zhong W, Cipres-Palacin G, Heath TD, Debs RJ. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J. Biol. Chem. 273 (40), 26164-26170 (1998).
111. Gaspar VM, Marques JG, Sousa F, Louro RO, Queiroz JA, Correia IJ. Biofunctionalized nanoparticles with pH-responsive and cell penetrating blocks for gene delivery. Nanotechnology 24(27), 1-5 (2013).
112. Chen HP, Liu XP, Dou Y et al. A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery. Biomaterials 34(16), 4159-4172 (2013).
113. Kim HK, Thompson DH, Jang HS, Chung YJ, Van Den Bossche J. pH-responsive biodegradable assemblies containing tunable phenyl-substituted vinyl ethers for use as efficient gene delivery vehicles. ACS Appl. Mater. Interfaces 5(12), 5648-5658 (2013).
114. Tseng WC, Su LY, Fang TY. pH responsive PEGylation through metal affinity for gene delivery mediated by histidine-grafted polyethylenimine. J. Biomed. Mater. Res. B Appl. Biomater. 101B(2), 375-386 (2013).
115. Zhao QH, Qiu LY. An overview of the pharmacokinetics of polymer-based nanoassemblies and nanoparticles. Curr. Drug Metab. 14(8), 832-839 (2013).
116. Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 56 (6), 1194-1198 (1996).
117. Iskandar SS, Jennette JC. Interaction of antigen load and antibody-response in determining heterologous protein nephritogenicity in inbred mice. Lab. Invest. 48 (6), 726-734 (1983).